| scholarly article | Q13442814 |
| P50 | author | Naoki Nishida | Q44537420 |
| P2093 | author name string | Yoshiaki Yamaguchi | |
| Yuko Oku | |||
| Fukiko Ichida | |||
| Keiichi Hirono | |||
| Yukiko Hata | |||
| Shojiro Ichimata | |||
| P2860 | cites work | The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms | Q28203734 |
| New perspectives on the prevalence of hypertrophic cardiomyopathy | Q28259498 | ||
| Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals | Q28607995 | ||
| The Genetic Basis for Cardiomyopathy | Q29300961 | ||
| A general framework for estimating the relative pathogenicity of human genetic variants | Q29615730 | ||
| A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). | Q33163399 | ||
| Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy | Q33167938 | ||
| Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome | Q33603766 | ||
| Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass | Q33610845 | ||
| An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing | Q33655317 | ||
| Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy | Q34048715 | ||
| Hypertrophic cardiomyopathy: a systematic review | Q34117625 | ||
| Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
| The pathology of hypertrophic cardiomyopathy | Q35771667 | ||
| Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. | Q36399631 | ||
| Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. | Q50797373 | ||
| Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death. | Q52628940 | ||
| The "sigmoid septum". Variation in the contour of the left ventricular outt. | Q54138043 | ||
| Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy | Q56972986 | ||
| Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance | Q57418111 | ||
| Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients | Q67019025 | ||
| Relation between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy | Q68037630 | ||
| Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction | Q69726380 | ||
| Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients | Q70676010 | ||
| Evaluation of pathological criteria for diagnosis of hypertrophic cardiomyopathy | Q70793510 | ||
| Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy | Q78726625 | ||
| Hypertrophic cardiomyopathy | Q80172333 | ||
| Hypertrophic Cardiomyopathy: Clinical Update | Q88360650 | ||
| Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing | Q36712985 | ||
| Human genetic variation database, a reference database of genetic variations in the Japanese population | Q37060586 | ||
| Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy | Q37707887 | ||
| Genetics of hypertrophic cardiomyopathy: A review of current state | Q38736063 | ||
| Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy | Q38963414 | ||
| Asymmetrical hypertrophy of the heart in young adults | Q39319375 | ||
| Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review | Q39614414 | ||
| Muscle fiber disarray in common heart diseases | Q39827177 | ||
| Angled aorta ("sigmoid septum") as a cause of hypertrophic subaortic stenosis | Q39861036 | ||
| Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study | Q39896512 | ||
| Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy | Q40444308 | ||
| Hypertrophic cardiomyopathy — pathology and pathogenesis | Q40476828 | ||
| Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy. | Q41237982 | ||
| The current status of myocardial disarray in hypertrophic cardiomyopathy | Q41305578 | ||
| Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series | Q42503963 | ||
| Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy | Q42515078 | ||
| Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy | Q43013040 | ||
| Clinical course of hypertrophic cardiomyopathy in a regional United States cohort | Q43565120 | ||
| Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy | Q44063544 | ||
| Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy | Q44134258 | ||
| Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy | Q44423917 | ||
| Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage | Q45339581 | ||
| Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction. | Q47826134 | ||
| Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene | Q47957734 | ||
| Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation. | Q47971514 | ||
| Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases | Q48313740 | ||
| Epilepsy-related sudden unexpected death: targeted molecular analysis of inherited heart disease genes using next-generation DNA sequencing | Q48775549 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P577 | publication date | 2019-04-05 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Clinicopathological and Genetic Profiles of Cases with Myocytes Disarray-Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy. | |
| P478 | volume | 8 |
Search more.